Literature DB >> 2492364

A young type III hyperlipoproteinemic patient associated with apolipoprotein E deficiency.

H Mabuchi1, H Itoh, M Takeda, K Kajinami, T Wakasugi, J Koizumi, R Takeda, C Asagami.   

Abstract

A 13-year-old female patient had noticed tuberoeruptive xanthomas since 3 years of age. Her serum, VLDL, and IDL cholesterol levels were high (348, 158, and 60 mg/dL, respectively), while LDL and HDL cholesterol levels were 56 and 62 mg/dL, respectively. VLDL-cholesterol/serum triglyceride ratio was extremely high (0.86), suggesting type III hyperlipoproteinemia (HLP). Her apo E was undetectable by the single radial immunodiffusion studies and SDS-polyacrylamide gel electrophoresis. Her parents showed hypertriglyceridemia and her two siblings were normolipidemic, and their apo E levels were normal. Genomic DNA digested with BamHI or EcoRI did not show gross differences in the restriction fragment length between the apo-E-deficient patient and normal controls. Thus, apo E deficiency may be characterized by early appearance of clinical manifestations of type III HLP and higher VLDL-cholesterol/serum triglyceride ratio.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2492364     DOI: 10.1016/0026-0495(89)90249-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  17 in total

1.  Liver-directed gene transfer and prolonged expression of three major human ApoE isoforms in ApoE-deficient mice.

Authors:  K Tsukamoto; P Smith; J M Glick; D J Rader
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Authors:  G Feussner
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

3.  Effects of the absence of apolipoprotein e on lipoproteins, neurocognitive function, and retinal function.

Authors:  Angel C Y Mak; Clive R Pullinger; Ling Fung Tang; Jinny S Wong; Rahul C Deo; Jean-Marc Schwarz; Alejandro Gugliucci; Irina Movsesyan; Brian Y Ishida; Catherine Chu; Annie Poon; Phillip Kim; Eveline O Stock; Ernst J Schaefer; Bela F Asztalos; Joseph M Castellano; Tony Wyss-Coray; Jacque L Duncan; Bruce L Miller; John P Kane; Pui-Yan Kwok; Mary J Malloy
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

4.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Authors:  J A Piedrahita; S H Zhang; J R Hagaman; P M Oliver; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

5.  ApoE knockout and knockin mice: the history of their contribution to the understanding of atherogenesis.

Authors:  Godfrey S Getz; Catherine A Reardon
Journal:  J Lipid Res       Date:  2016-03-25       Impact factor: 5.922

6.  Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption.

Authors:  S H Zhang; R L Reddick; B Burkey; N Maeda
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

7.  A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.

Authors:  Y Huang; A von Eckardstein; S Wu; N Maeda; G Assmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

8.  A 10-bp deletion in the apolipoprotein epsilon gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia.

Authors:  G Feussner; J Dobmeyer; H J Gröne; S Lohmer; S Wohlfeil
Journal:  Am J Hum Genet       Date:  1996-02       Impact factor: 11.025

9.  Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland.

Authors:  Kaijin Wu; Corrine Joffre; Xiaodong Li; Michelle MacVeigh-Aloni; Melinda Hom; Juliana Hwang; Chuanqing Ding; Stephane Gregoire; Lionel Bretillon; Jiang F Zhong; Sarah F Hamm-Alvarez
Journal:  Exp Eye Res       Date:  2009-04-02       Impact factor: 3.467

10.  Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E.

Authors:  S Fazio; Y L Lee; Z S Ji; S C Rall
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.